Atypical hyperplasia of the breast: Clinical cases and management strategies.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review and expert opinion based on illustrative case scenarios
PubMed 37400158 · doi:10.3949/ccjm.90a.22098
What was done
This is a narrative review presenting five clinical case scenarios to describe management and risk-reduction strategies for atypical breast hyperplasia identified on image-guided biopsy.
What was found
The abstract reports no numerical findings, odds ratios, or risk estimates. It identifies atypical hyperplasia as a marker of increased lifetime breast cancer risk and reviews management options including preventive endocrine therapy, enhanced surveillance imaging, and lifestyle modifications.
Why it matters
It provides practical clinical guidance for risk counseling and management tailored to distinct presentations of atypical breast hyperplasia.
Limits
The publication is an educational narrative review and expert consensus rather than an empirical trial or systematic review. The abstract provides no original cohort data or quantitative comparative outcomes.
Cited by
- supports A breast biopsy showing atypia significantly increases a woman's lifetime risk of developing breast cancer.